NASDAQ:CATB

Catabasis Pharmaceuticals Earning Date

USA |NASDAQ |USD

CATB Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $-0.77 $-5.34 $-3.36
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $0.00 $0.00 $0.00

Catabasis Pharmaceuticals's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

CATB Earnings Date & History Chart

CATB Earnings & Revenue Forecast

CATB Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.86 $-1.26 $-0.63
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-33.61 $-52.20 $-22.20
Dec 2022 4 $-3.04 $-3.90 $-2.45

CATB Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.86 $-0.22 $-0.28
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-33.61 $-5.20 $-6.30
Dec 2022 0 / 0 $-3.04 $-0.57 $-0.77

CATB Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $0.00 $0.00 $0.00
Dec 2022 4 $0.00 $0.00 $0.00

CATB Earnings Date & Revenue History

CATB Earnings History

|
Show More
Show More

CATB Revenue History

|
Show More
Show More

Catabasis Pharmaceuticals Next Earnings Date & Report

CATB Next Earnings Date & Report Preview: Sep 2021 (FQ)

CATB's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 4 analysts, the average EPS estimation for Catabasis Pharmaceuticals's next quarterly earnings is $-0.77, with a low EPS estimation of $-1.14, and a high estimation of $-0.64.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.77, the last 2 month trend is $-0.15, and the 3 month trend is $-0.20.

Based on 2 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Catabasis Pharmaceuticals Previous Earnings Dates & Reports

CATB Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Catabasis Pharmaceuticals's previous earnings date was Aug 9, 2021 for its fiscal quarter ended Jun 30, 2021.

CATB's earnings per share (EPS) was $-5.34, missing the consensus analysts forecast of $-1.82 by -193.41%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -88.29%, and lower than the same period a year before (Jun 2020) by 67.92%.

Revenues were $0.00.

The company reported a net income of $-7.47M.

Free cash flow for the quarter was $-16.14M , compared to $-8.74M last quarter and $-7.49M a year before.

CATB ended the quarter with $655.00K in total debt, a decrease of -25.65% compared to the previous quarter, and a decrease of -51.94% compared to the same quarter a year before.

CATB Previous Earnings Date & Report Recap: Dec 2020 (FY)

Catabasis Pharmaceuticals's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.

CATB's earnings per share (EPS) was $-12.18, missing the consensus analysts forecast of $-2.01 by 505.97% , and higher than the previous year's EPS (Dec 2019) by -13.62%.

Revenues were $0.00.

The company reported a net income of $-37.30M.

Catabasis Pharmaceuticals reported a free cash flow of $-32.52M for its fiscal year, compared to $-26.58M a year ago.

The company ended the fiscal year with $1.05M in total debt, a decrease of -53.57% compared to the previous year.